Non-parametric comparison of relative versus cause-specific survival in Surveillance, Epidemiology and End Results (SEER) programme breast cancer patients

Cancer-related mortality can be measured by two dissimilar methods: NAcause-specific survival (based on mortality attributed to a specific cause), and relative survival (based on mortality relative to a matched cohort). We used both methods to determine actuarial survival in a population of 119 502 breast cancer patients from the Surveillance, Epidemiology and End Results (SEER) programme data set, with 20 years of follow-up. The population was divided into four strata by patient age and tumour stage. In all strata, there was only minimal deviation between the two survival methods. Of particular interest was the cause-specific treatment of patients recorded as dead of unknown cause, i.e. those deaths that could not be attributed with certainty to either ‘breast cancer’ or to ‘other causes’. Findings suggest that the most reliable results may be obtained by apportioning these deaths between ‘dead of cause’ and ‘withdrawn at the time of death’. This apportionment is based on the relative number of deaths attributed to ‘breast cancer’ versus ‘other causes’.

[1]  V T Farewell,et al.  The analysis of failure times in the presence of competing risks. , 1978, Biometrics.

[2]  N Keiding,et al.  A Cox regression model for the relative mortality and its application to diabetes mellitus survival data. , 1985, Biometrics.

[3]  Buckley Jd,et al.  Additive and multiplicative models for relative survival rates. , 1984 .

[4]  G. Enderlein,et al.  Chiang, Ch. L.: Introduction to Stochastic Processes in Biostatistics. Wiley, & Sons, Inc., New York, London, Sydney 1968. 301 S., 1 Abb., 25 Tab., Preis 131 s , 1970 .

[5]  T. Hakulinen,et al.  A computer program package for relative survival analysis. , 1985, Computer programs in biomedicine.

[6]  T. Hakulinen.  On long-term relative survival rates. , 1977, Journal of chronic diseases.

[7]  F. Ederer,et al.  The relative survival rate: a statistical methodology. , 1961, National Cancer Institute monograph.

[8]  M Vaeth,et al.  Simple parametric and nonparametric models for excess and relative mortality. , 1989, Biometrics.

[9]  T. Panzarella,et al.  Analysis of cause-specific failure endpoints using simple proportions: an example from a randomized controlled clinical trial in early breast cancer. , 1998, International journal of radiation oncology, biology, physics.

[10]  S. Program.  Cancer patient survival , 1976 .

[11]  L. Ries,et al.  Survival results depend on the staging system. , 1992, Seminars in surgical oncology.

[12]  C. L. Chiang.  A STOCHASTIC STUDY OF THE LIFE TABLE AND ITS APPLICATIONS III. THE FOLLOW-UP STUDY WITH THE CONSIDERATION OF COMPETING RISKS"'2 , 1961 .

[13]  D. Schottenfeld,et al.  Adjustment of long-term survival rates for deaths due to intercurrent disease. , 1969, Journal of chronic diseases.

[14]  O Wong.  A competing-risk model based on the life table procedure in epidemiological studies. , 1977, International journal of epidemiology.

[15]  Harlley E. McKean,et al.  Introduction to Stochastic Processes in Biostatistics , 1969 .

[16]  Stephanie Green,et al.  Clinical Trials in Oncology , 1997 .

[17]  M Gail,et al.  A review and critique of some models used in competing risk analysis. , 1975, Biometrics.

[18]  Laurence L. George,et al.  The Statistical Analysis of Failure Time Data , 2003, Technometrics.

[19]  E. Slud,et al.  Competing risks bias arising from an omitted risk factor. , 1989, American journal of epidemiology.

[20]  Michael C. Minnotte,et al.  Noncancer deaths in white adult cancer patients. , 1993, Journal of the National Cancer Institute.

[21]  J BERKSON,et al.  Carcinoma and other malignant lesions of the stomach. , 1949, Mississippi Valley medical journal.

[22]  T. Hakulinen,et al.  Testing equality of relative survival patterns based on aggregated data. , 1987, Biometrics.

[23]  R. Gelber,et al.  Improved methodology for analyzing local and distant recurrence. , 1990, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[24]  R. P. Oates.  Forces of mortality among breast cancer patients. , 1976, Journal of chronic diseases.

[25]  L. Ries,et al.  Effect of Changes in Cancer Classification and the Accuracy of Cancer Death Certificates on Trends in Cancer Mortality , 1990, Annals of the New York Academy of Sciences.

[26]  A. Hanlon,et al.  The impact of tamoxifen on breast recurrence, cosmesis, complications, and survival in estrogen receptor-positive early-stage breast cancer. , 1996, International journal of radiation oncology, biology, physics.

[27]  J Benichou,et al.  Estimates of absolute cause-specific risk in cohort studies. , 1990, Biometrics.

[28]  W. R. Buckland.  Theory of Competing Risks , 1978 .

[29]  E. Feuer,et al.  Cumulative cause-specific mortality for cancer patients in the presence of other causes: a crude analogue of relative survival. , 2000, Statistics in medicine.

[30]  J. Cornfield,et al.  The estimation of the probability of developing a disease in the presence of competing risks. , 1957, American journal of public health and the nation's health.

[31]  C. Brown.  The statistical comparison of relative survival rates. , 1983, Biometrics.

[32]  J. Kalbfleisch,et al.  The Statistical Analysis of Failure Time Data , 1980 .

[33]  J. Cornfield.  The University Group Diabetes Program. A further statistical analysis of the mortality findings. , 1971, JAMA.

[34]  Timo Hakulinen,et al.  Regression Analysis of Relative Survival Rates , 1987 .

[35]  E. Slud,et al.  How dependent causes of death can make risk factors appear protective. , 1988, Biometrics.

[36]  F. Ederer,et al.  Maximum utilization of the life table method in analyzing survival. , 1958, Journal of chronic diseases.